Cargando…
Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer
BACKGROUND: HSVtk/ganciclovir (GCV) gene therapy has been extensively studied in tumors and relies largely on the gene expression of HSVtk. Most studies, however, have failed to demonstrate any significant benefit of a controlled gene expression strategy in cancer treatment. The Tet-On system is com...
Autores principales: | Zi-Bo, LI, Zhao-Jun, ZENG, Qian, CHEN, Sai-Qun, LUO, Wei-Xin, HU |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463003/ https://www.ncbi.nlm.nih.gov/pubmed/16539746 http://dx.doi.org/10.1186/1471-2407-6-66 |
Ejemplares similares
-
Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors
por: Han, Ye, et al.
Publicado: (2010) -
Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport
por: Buursma, A R, et al.
Publicado: (2004) -
Transduction of a Fiber‐mutant Adenovirus for the HSVtk Gene Highly Augments the Cytopathic Effect towards Gliomas
por: Shinoura, Nobusada, et al.
Publicado: (2000) -
Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV
por: Liu, Fengting, et al.
Publicado: (2018) -
Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV
por: Liu, Fengting, et al.
Publicado: (2019)